Reaction Details |
| Report a problem with these data |
Target | Urokinase-type plasminogen activator |
---|
Ligand | BDBM50231521 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_460612 (CHEMBL927669) |
---|
IC50 | 40000±n/a nM |
---|
Citation | Frederickson, M; Callaghan, O; Chessari, G; Congreve, M; Cowan, SR; Matthews, JE; McMenamin, R; Smith, DM; Vinkovic, M; Wallis, NG Fragment-based discovery of mexiletine derivatives as orally bioavailable inhibitors of urokinase-type plasminogen activator. J Med Chem51:183-6 (2008) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Urokinase-type plasminogen activator |
---|
Name: | Urokinase-type plasminogen activator |
Synonyms: | 3.4.21.73 | PLAU | U-plasminogen activator | UROK_HUMAN | Urokinase | Urokinase-type plasminogen activator (uPA) | Urokinase-type plasminogen activator chain B | Urokinase-type plasminogen activator long chain A | Urokinase-type plasminogen activator short chain A | Urokinase-type plasminogen activator/surface receptor | uPA |
Type: | Enzyme |
Mol. Mass.: | 48528.62 |
Organism: | Homo sapiens (Human) |
Description: | P00749 |
Residue: | 431 |
Sequence: | MRALLARLLLCVLVVSDSKGSNELHQVPSNCDCLNGGTCVSNKYFSNIHWCNCPKKFGGQ
HCEIDKSKTCYEGNGHFYRGKASTDTMGRPCLPWNSATVLQQTYHAHRSDALQLGLGKHN
YCRNPDNRRRPWCYVQVGLKLLVQECMVHDCADGKKPSSPPEELKFQCGQKTLRPRFKII
GGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVYLG
RSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICL
PSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKML
CAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIR
SHTKEENGLAL
|
|
|
BDBM50231521 |
---|
n/a |
---|
Name | BDBM50231521 |
Synonyms: | 4-(2-aminoethoxy)-3,5-dichlorobenzoic acid | 4-[(2-amino)ethoxy]-3,5-dichlorobenzoic acid | CHEMBL401484 |
Type | Small organic molecule |
Emp. Form. | C9H9Cl2NO3 |
Mol. Mass. | 250.079 |
SMILES | NCCOc1c(Cl)cc(cc1Cl)C(O)=O |
Structure |
|